The CementWorks, LLC.

Share this article:
The CementWorks,LLC.
The CementWorks,LLC.
641 Sixth Ave, 5th Floor
New York, NY 10011
Phone: 212-524-6288 · Fax:212-524-6299
Email: rviray@thecementworks.com · Web: www.thecementworks.com
Founded: 2000

Officers: Partners: Susan Miller, Rico Viray; EVPs: Ed Cowen, Reid Saleeby, Peter Zamiska; SVPs: Andrea Bast, Lily Chow, Ed Puydak; David Garson, SVP/creative director, art; Daljit Telymonde, SVP/creative director.

Financial data:
Source20052004
Gross Income$8.3 mil$5.5 mil
Billings$69.5 mil$38.3 mil
US Employees4932

U.S. billings breakdown by media/source:
Medium20052004
Journals29.0%25.0%
Conventions/ exhibits5.0%5.0%
Direct marketing2.0%2.0%
Sales Materials30.0%31.0%
Consumer Media4.0%4.0%
Branding, strategy programs30.0%32.0%


Healthcare accounts: UCB: Cimzia (global, U.S.); Johnson & Johnson: Tibotec (global, U.S.), TMC114, TMC-125; Pfizer/Boehringer-Ingelheim: Spiriva; Novartis Ophthalmology Portfolio: Visudyn, Genteal Portfolio, Vitalux; Bayer diabetes division: Ascensia Breeze, Ascensia Contour; Alpharma USPD Inc.: Feverall; Pfizer: advocacy program; Medco Health Solutions; Eastern Dental.

Accounts gained (10): Novartis ophthalmology portfolio: Visudyn, Genteal Portfolio, Vitalux; Bayer diabetes division: Ascensia Breeze, Ascensia Contour; Johnson & Johnson: TMC-114, TMC-125; UCB: global; Medco Health Solutions; Eastern Dental.

Accounts lost (1): Vicuron Pharmaceuticals, Inc.

New hires: Daljit Telymonde, SVP/creative director.

Offices: Raleigh, N.C.
Share this article:
close

Next Article in Agency Gallery

Email Newsletters

More in Agency Gallery

Private View: Creating Compelling Experiences

Private View: Creating Compelling Experiences

In today's multi-channel environment, game-changing ideas blend creativity and sensory ideation to create a meaningful customer experience

Putting consumers at the center of your universe

Putting consumers at the center of your universe

The question should be: How do you simplify and identify the moments that mean the most to customers?

Did "pay-to-play" confab help Zohydro approval?

Did "pay-to-play" confab help Zohydro approval?

US senators Joe Manchin (D-WV) and David Vitter (R-LA) are asking whether a "pay-to-play" meeting between drug industry executives and FDA officials influenced the agency's approval of Zohydro